| (USD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 13.68M | — |
| Operating expense | — | — |
| Net income | -30.34M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ADAPY returned -52.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +3.8% |
| 1 year | -52.6% |
| 5 years | -99.5% |
| 10 years | -99.6% |
| All-time high | $18.33 (Jun 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ADAPY would be worth today ›No. Adaptimmune Therapeutics plc has not paid a dividend in the past 12 months.
Adaptimmune Therapeutics plc is part of the Healthcare sector.
Adaptimmune Therapeutics plc has a market cap of 7.16M USD, based on the latest quote.
